Stock screener

BEAM

Conviction 55HealthcareScan · Tue, Sep 8, 2026
BEAM$26.83-9.54%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2.09M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Beam Therapeutics Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.beamtx.com ↗
Price26.83
Change-9.54%
Gap-8.97%
Rel volume5.08×
Avg volume1.91M
Avg $ vol53.95M
SMA 2028.54
SMA 5029.19
SMA 20028.55
Price vs 50-8.09%
Price vs 200-6.03%
MA stackmixed
50/200 cross—
Supertrendup · 25.37
RSI (14)42
MACD hist-0.06
MACD crossbear · 0d
Stoch %K / %D27 / 52
ADX (14)18
+DI / −DI18 / 28
RSI divergence—
MACD divergence—
ATR %+6.66%
ADR %4.93%
52w high37.92
52w low19.88
From 52w high-29.25%
Above 52w low+34.96%
New 52w highNo
SqueezeOff
Bollinger width20.12%
%B0.20
Donchian pos27.46%
Donchian high31.48
Donchian low25.07
AVWAP (52w high)28.96
vs AVWAP high-7.35%
AVWAP (52w low)27.90
vs AVWAP low-3.84%
OBV trendFlat
Chaikin MF (20)0.26
Today vs 20d5.08×
Avg vol (14d)2.09M
Avg vol (20d)1.91M
Avg $ vol (20d)53.95M
Market cap2.77B
RS 3m (vs SPY)-3.54%
RS 6m (vs SPY)-2.79%
RS line new highNo
Trend template4/8
Technical rank30.0
1 week-8.83%
1 month-2.37%
3 months-9.91%
6 months-2.86%
1 year+28.50%
YTD-1.14%
P/E-34.64
P/B2.60
P/S19.83
P/FCF-7.70
EPS-0.8100
Div yield—
ROE-7.49%
ROA-5.77%
Debt/Eq0.09
Current14.57
EV/EBITDA-7.34
Gross margin—
Net margin-57.24%
Rev growth120.01%
EPS growth78.77%
Price target52.30
Target upside94.93%
Analyst ratingBuy
Institutional118.54%
Ent. value2.65B
Revenue490K
Net income-122.68M
Gross profit—
Free cash flow-360.05M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out102.88M
Employees522
ListedThu, Feb 6, 2020
Free float79.74M
Float %78.3%
Short interest24.37M
Days to cover16.1d
Short volume64.8%
Squeeze score97 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.18 vs −$1.00
Last surprise-18.0% miss
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank30.0 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance30.83
Support24.67
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 18 – Jun 24
    2 scans
  2. Breaking out now
    Jun 26
    1 scan
  3. Broke out
    Jun 29
    1 scan

Recent news

Congress activity

Disclosed STOCK Act trades in BEAM

All disclosures →
No recent disclosed trades by Congress in BEAM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BEAM · 6 buys · 4 sells

InsiderSideShares
FMR LLC
10% owner · Common Stock · 2026-06-26
Sell251.49K
FMR LLC
10% owner · Common Stock · 2026-06-25
Sell33.37K
Ciaramella Giuseppe
President · Common Stock · 2026-06-17
Exercise6.5K
Ciaramella Giuseppe
President · Common Stock · 2026-06-17
Exercise29K
Ciaramella Giuseppe
President · Stock Option (Right to Buy) · 2026-06-17
Exercise6.5K
Ciaramella Giuseppe
President · Stock Option (Right to Buy) · 2026-06-17
Exercise29K
Shaw Christi
Director · Stock Option (Right to Buy) · 2026-06-03
Grant19.68K
Fishman Mark
Director · Stock Option (Right to Buy) · 2026-06-03
Grant19.68K
MARAGANORE JOHN
Director · Stock Option (Right to Buy) · 2026-06-03
Grant19.68K
COOPER GRAHAM K
Director · Stock Option (Right to Buy) · 2026-06-03
Grant19.68K

SEC filings

EDGAR filings in BEAM · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.